This compound is a nucleoside phosphoramidite building block designed for oligonucleotide synthesis. It features a DMT-protected 5'-hydroxyl group and a cyanoethyl phosphoramidite moiety at the 3'-position, enabling automated solid-phase DNA/RNA assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2747890-15-7
DMTr-TNA-5MeU amidite
pharmaceutical intermediate
2'-O-Hexadecyl-U-CE-Phosphoramidite
pharmaceutical intermediate
5'-Dimethoxytrityl-3'-deoxythymidine 2'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
pharmaceutical intermediate
Ac-dA Phosphoramidite
pharmaceutical intermediate
L-Leucine tert-butyl ester hydrochloride
pharmaceutical intermediate
Alogliptin Impurity 4
pharmaceutical intermediate
(+)-2-aminopropanol
pharmaceutical intermediate
1,3-Dimethyl-5-pyrazolone
pharmaceutical intermediate
3-[[(2R,3R,4R,5R)-2-[(1S)-1-[bis(4-methoxyphenyl)-phenylmethoxy]ethyl]-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile
PKWBIYABXKYVJR-UYALASEFSA-N
C[C@@H]([C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)OC)OP(N(C(C)C)C(C)C)OCCC#N)OC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC
—